CHA News Article

FDA Pulls Generic Version of Wellbutrin

The Food and Drug Administration (FDA) has issued a press release stating that new data indicate Budeprion XL 300 mg, a generic version of the antidepressant Wellbutrin XL 300 mg, does not produce the same therapeutic results as its name-brand counterpart. Imax Laboratories, Inc., which manufactures the generic, and Teva Pharmaceuticals USA, Inc., which markets it, stopped shipping the drug and have withdrawn it from the market. More information is available in the FDA press release and a list of 20 questions and answers.